These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 23386570

  • 1. Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons.
    Sunwoo MK, Kim KM, Hong JY, Sohn YH, Lee PH.
    Mov Disord; 2013 Jul; 28(8):1152-3. PubMed ID: 23386570
    [No Abstract] [Full Text] [Related]

  • 2. Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.
    Růzicka E, Urgosík D, Jech R, Roth J, Vymazal J, Mecír P, Vladyka V.
    Mov Disord; 2005 Jun; 20(6):759-62. PubMed ID: 15782419
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
    Pita Lobo P, Coelho M, Mestre TA, Rosa MM, Ferreira JJ.
    Mov Disord; 2013 Aug; 28(9):1212-4. PubMed ID: 23861327
    [No Abstract] [Full Text] [Related]

  • 5. The blood-brain barrier is intact after levodopa-induced dyskinesias in parkinsonian primates--evidence from in vivo neuroimaging studies.
    Astradsson A, Jenkins BG, Choi JK, Hallett PJ, Levesque MA, McDowell JS, Brownell AL, Spealman RD, Isacson O.
    Neurobiol Dis; 2009 Sep; 35(3):348-51. PubMed ID: 19501164
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Levodopa-induced dyskinesia in MPTP-treated macaques is not dependent on the extent and pattern of nigrostrial lesioning.
    Guigoni C, Dovero S, Aubert I, Li Q, Bioulac BH, Bloch B, Gurevich EV, Gross CE, Bezard E.
    Eur J Neurosci; 2005 Jul; 22(1):283-7. PubMed ID: 16029219
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
    Ferrara JM, Adam OR, Ondo WG.
    Arch Neurol; 2010 Jan; 67(1):114-5. PubMed ID: 20065139
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C, Silverdale MA, Varma A, Dick JP, Kellett MW.
    Mov Disord; 2009 Dec 15; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract] [Full Text] [Related]

  • 13. L-DOPA treatment selectively restores spine density in dopamine receptor D2-expressing projection neurons in dyskinetic mice.
    Suárez LM, Solís O, Caramés JM, Taravini IR, Solís JM, Murer MG, Moratalla R.
    Biol Psychiatry; 2014 May 01; 75(9):711-22. PubMed ID: 23769604
    [Abstract] [Full Text] [Related]

  • 14. Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia.
    Aubert I, Guigoni C, Håkansson K, Li Q, Dovero S, Barthe N, Bioulac BH, Gross CE, Fisone G, Bloch B, Bezard E.
    Ann Neurol; 2005 Jan 01; 57(1):17-26. PubMed ID: 15514976
    [Abstract] [Full Text] [Related]

  • 15. Commentary.
    Fox S.
    Mov Disord; 2013 Aug 01; 28(9):1214-5. PubMed ID: 23857852
    [No Abstract] [Full Text] [Related]

  • 16. Drebrin immunoreactivity in the striatum of a rat model of levodopa-induced dyskinesia.
    Nishijima H, Arai A, Kimura T, Mori F, Yamada J, Migita K, Wakabayashi K, Baba M, Ueno S, Tomiyama M.
    Neuropathology; 2013 Aug 01; 33(4):391-6. PubMed ID: 23241013
    [Abstract] [Full Text] [Related]

  • 17. Metabotropic glutamate receptor II in the brains of Parkinsonian patients.
    Samadi P, Rajput A, Calon F, Grégoire L, Hornykiewicz O, Rajput AH, Di Paolo T.
    J Neuropathol Exp Neurol; 2009 Apr 01; 68(4):374-82. PubMed ID: 19287314
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Contribution of pre-synaptic mechanisms to L-DOPA-induced dyskinesia.
    Carta M, Bezard E.
    Neuroscience; 2011 Dec 15; 198():245-51. PubMed ID: 21840375
    [Abstract] [Full Text] [Related]

  • 20. Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    de Souza A, de Souza RJ.
    Parkinsonism Relat Disord; 2017 Oct 15; 43():120-121. PubMed ID: 28729089
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.